Skip to main content

Advertisement

SpringerLink
Log in

Inhibition of pathological angiogenesis of Chinese medicine against liver fibrosis

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Pathological angiogenesis of liver which includes liver sinusoidal capillarization due to lose of fenestraes of liver sinusoidal endothelial cells (LSECs) and formation of new vascular, is a crucial mechanism responsible for origination and development of liver fifibrosis and closely involves in the development of cirrhosis and hepatic cancer. Anti-neovascularization medicine such as sorafenib can decrease portosystemic shunts, improve splanchnic hyperdynamic circulation, lower portal hypertension, while it can not be applied in clinic due to its serious toxic and side reactions. Chinese herbal formula can effectively inhibit pathological angiogenesis of liver, improve microcirculation of liver, and decrease the probability of gastrointestinal hemorrhage in cirrhotic patients. Different Chinese herbal formula are of different characteristics on inhibiting pathological angiogenesis in liver fifibrosis, which partly explains synergistic effect of different compatibility of Chinese materia medica and opens up good vista for Chinese medicine against liver fifibrosis through inhibiting angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ding BS, Cao ZW, Lis R, Nolan DJ, Guo PP, Simons M, et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 2014;505:97–102.

    Article  PubMed  Google Scholar 

  2. Lee JS, Semela D, Iredale J, Shah VH. Sinusoidal remodeling and angiogenesis: a new function for the liverspecific pericyte? Hepatology 2007;45:817–825.

    Article  CAS  PubMed  Google Scholar 

  3. Straub AC, Stolz DB, Ross MA, Hernández-Zavala A, Soucy NV, Klei LR, et al. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology 2007;45:205–212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mehta G, Gustot T, Mookerjee RP, Garcia-Pagan JC, Fallon MB, Shah VH, et al. Inflammation and portal hypertension— the undiscovered country. J Hepatol 2014;61:155–163.

    Article  PubMed  Google Scholar 

  5. Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 2010;53:976–980.

    Article  PubMed  Google Scholar 

  6. Lin HC, Huang YT, Yang YY, Lee PC, Hwang LH, Lee WP, et al. Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. J Gastroenterol Hepatol 2014;29:1073–1082.

    Article  CAS  PubMed  Google Scholar 

  7. Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009;49:1245–1256.

    Article  CAS  PubMed  Google Scholar 

  8. Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J, Arroyo V, Rodés J, et al. Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007;46:1919–1926.

    Article  CAS  PubMed  Google Scholar 

  9. Gu J, Zhang Q, Xue D, Cai H, Xu L. A randomized controlled study of Fuzheng Huayu Capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis. Evid Based Complement Alternat Med 2013;2013:697–715.

    Google Scholar 

  10. Lu X, Liu P, Liu C. Effect of Fuzheng Huayu Recipe on hepatic sinusoid capillarization in the rat of dimethyl nitrosamine-induced hepatic fibrosis. J Tradit Chin Med (Chin) 2003;44:136–139

    Google Scholar 

  11. Lyu J, Tan Y, Zhao ZM, Huang K, Shen L, Tao YY, et al. Fuzheng Huayu Formula exerted anti-liver fibrosis through inhibiting angiogenesis. World Chin Med (Chin) 2015;10:186–191.

    Article  Google Scholar 

  12. Tang ZP, Liu P, Wang XB. Effect of Cordyceps mycelia extract on hepatic sinusoidal endoth-elial cells permeability in dimethylnitrosamine-induced liver fibrosis in rats. Chin J New Drugs Clin Remed (Chin) 2006;25:713–717.

    CAS  Google Scholar 

  13. Wang XB, Liu P, Tang ZP. Intervening and therapeutic effect of Cordyceps mycelia extract on liver cirrhosis induced by dimethylnitrosamine in rats. Chin J Integr Tradit West Med (Chin) 2008;28:617–622.

    Google Scholar 

  14. Wang XB, Liu P, Tang ZP. Effect of Cordyceps mycelia extract on injury and phenotype shift of liver sinusoidal endothelial cells in rats with dimethylnitrosamine-induced liver cirrhosis. J Beijing Univ Tradit Chin Med (Chin) 2008;31:448–451.

    Google Scholar 

  15. Du JX, Sun MY, Du GL, Li FH, Liu C, Mu YP, et al. Ingredients of Huangqi Decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway. BMC Complement Alternat Med 2012;12:1–11.

    Article  Google Scholar 

  16. Liu C, Wang GQ, Chen GF, Mu YP, Zhang LJ, Hu XD, et al. Huangqi Decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis. BMC Complement Alternat Med 2012;12:1–8.

    Article  CAS  Google Scholar 

  17. Du GL, Liu P, Wang L, Tan SZ, Long AH, Mu YP, et al. Expression of matrix metalloproteinase 9/13 (MMP-9/13) and tissue inhibitor of metalloproteinase 1/2 (TIMP-1/2) in liver fibrosis induced by porcine serum and Xiayuxue Decoction on it. Chin J Exper Tradit Med Formu (Chin) 2009;15:48–51.

    Google Scholar 

  18. Du JX, Liu P, Sun MY, Tao Q, Zhang LJ, Chen GF, et al. Chinese herbal medicine Xiayuxue Decoction inhibits liver angiogenesis in rats with carbon tetrachloride-induced liver fibrosis. J Chin Integr Med (Chin) 2011;9:878–887.

    Article  Google Scholar 

  19. Zhang LJ, Sun MY, Ning BB, Zhang WM, Chen GF, Mu YP, et al. Xiayuxue Decoction attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice. Chin J Integr Med 2014;20:516–523.

    Article  PubMed  Google Scholar 

  20. Zhou YN, Sun MY, Mu YP, Yang T, Ning BB, Ren S, et al. Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl4 in mice. J Ethnopharmacol 2014;153:659–666.

    Article  PubMed  Google Scholar 

  21. Mu YP, Liu P, Wang L, Liu C, Wang GQ, Du JX, et al. Hepatic gene expression analysis of carbon tetrachlorideinduced rat cirrhosis identifies distinct effects of Yiguanjian Decoction. Modern Tradit Chin Med Mater Med—World Sci Technol (Chin) 2007;9:43–54.

    Google Scholar 

  22. Zhou YN, Mu YP, Fu WW, Ning BB, Du GL, Chen JM, et al. Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice. BMC Complement Alternat Med 2015;15:1–9.

    Article  Google Scholar 

  23. Hano H, Takasaki S, Kobayashi H, Koyama T, Lu T, Nagatsuma K. In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained. Virchows Arch 2013;462:533–540.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shanghai University of Traditional Chinese Medicine, Shanghai, 201023, China

    Ping Liu  (刘 平)

Authors
  1. Ping Liu  (刘 平)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Liu  (刘 平).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, P. Inhibition of pathological angiogenesis of Chinese medicine against liver fibrosis. Chin. J. Integr. Med. 22, 569–572 (2016). https://doi.org/10.1007/s11655-016-2468-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2468-3

Keywords

Search

Navigation